Qube Research & Technologies (QRT)
ABVX

Qube Research & Technologies (QRT)’s Abivax ABVX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Buy
+81,216
New +$9.19M 0.01% 1246
2026
Q1 		– Sell
-2,037
Closed -$275K – 3485
2025
Q4 		$275K Buy
+2,037
New +$222K ﹤0.01% 2974

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ABVX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Abivax (ABVX) in Q2 2026: 81,216 shares worth $10.8M. The stake represents 0.01% of the portfolio and ranks #1246 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ABVX as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 81,216 shares of Abivax worth $10.8M as of Q2 2026.
  • Abivax was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Abivax made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1246 holding.
  • Qube Research & Technologies (QRT) first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.